ADC Therapeutics SA IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| ADC Therapeutics SA | ADCT - NYSE |
$16.00-$18.00 | $19.00 | $30.00 | 12.3 million | 5/15/2020 |
| Morgan Stanley, BofA Merrill Lynch, Cowen | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): 1st Filed 2019-09-06 Terms Added 2019-09-23 Filed 2020-04-24 Terms Added 2020-05-11 Terms Changed 2020-05-14 | ||||||
ADC Therapeutics SA Quote & Chart - Click for current quote - ADCT
IPO Boutique aggregates information on public companies and private companies, such as "ADCT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About ADC Therapeutics SA (adapted from ADC Therapeutics SA prospectus):
They are a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ADCT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.